RhythmScience Inc.

Thinking beyond PaceArt? Is Rhythm360 on the shortlist? Vendor‑neutral CIED & ambulatory device data in one cloud platform, legacy data capability, and tight EHR integration for modern EP workflows. #EPeeps #Cardiology #PaceArt

Congrats to Emma Asatryan, PharmD, on presenting her AI-driven research to optimize GDMT for heart failure care at #ASHP Midyear ’25! Proud to support innovation that’s shaping more personalized, effective cardiology treatments. 💙 #GDMT #Cardiology #HeartFailure

Managing device recalls shouldn't slow your clinic down. Our latest Rhythm360 update brings smarter tools for faster and more accountable recall tracking. Check it out: rhythm360.io/blog/rhythm360… #EPeeps #Cardiology #HealthTech

Thrilled to see CMS grant National Coverage Determination for CCM therapy—a major win for heart failure patients and providers! 🚀 Expanding access to innovative, evidence-based care transforms lives. Congrats to #ImpulseDynamics ❤️ #HeartFailure

In San Francisco next week? Join us for happy hour on Monday, Oct 27 - great drinks, great company, and even better conversation! Don't miss it! ❤️💡 #Cardiology #SanFrancisco #Networking

Heading to San Francisco? We'd love to meet up to share how we are making cardiac data smarter. #Cardiology #HealthInnovation

This weekend's symposium continued to highlight the challenge cardiologists face managing massive cardiac data. Proud to see how Rhythm360 is turning overload into actionable insights to empower better patient outcomes #Cardiology #Innovation #EPeeps rhythm360.io

Today’s the day! Excited to kick off the RhythmScience Symposium, bringing together leaders and innovators to advance the future of cardiac care. Stay tuned for cutting-edge insights and expert discussions ❤️💡 #Cardiology #Innovation #EPeeps

The reality is—scheduling an in-person visit just to increase a beta-blocker dose or add an SGLT2 inhibitor is a waste of time and resources. Cardiologists don’t have the capacity to see patients every 1–2 weeks to uptitrate GDMT, and most health systems lack the infrastructure to do it for them. The result: both clinical inertia and administrative inertia. That’s why we need new solutions. I’m excited to partner with @rhythmsci and CEO/founder @shawnkumar1000 to bring HF-AI to market. HF-AI is a comprehensive heart failure solution that uses home blood pressure readings to remotely titrate guideline-directed therapy. In TURING-HF (JACC: Heart Failure, 2025), cardiologists accepted 90.8% of HF-AI recommendations. It doubled GDMT use, enabled 80% of medication changes remotely, and reduced hospitalizations by 74%. Building HF-AI was step one. Validating it in a clinical trial was step two. Getting it into the hands of clinicians through RhythmScience is how we change outcomes. By integrating HF-AI into Rhythm360—alongside implantables and home BP data—we can personalize heart failure care at scale. And ultimately—save lives. @HanCardiomd @DrMarthaGulati @gcfmd @MKIttlesonMD

RhythmScience is proud to license the groundbreaking HF-AI algorithm from Cedars-Sinai, revolutionizing heart failure care with AI-powered personalized therapy! Clinical validation shows 90.8% cardiologist agreement & 74% fewer hospitalizations. Curious to see how? Let's Discuss!

Inspired by the engaging discussions and innovation at #HRx2025, insightful sessions fueling new ideas for advancing cardiac care. Now heading to #HeartsinSonoma with UCSF for more heart failure updates. Follow for insights and join the conversation! #Cardiology

Excited for day one of #HRX2025 If you are in Atlanta, we’d love to connect and talk all things cardiac innovation. See you at booth 432! #Cardiology

Excited to welcome Mac Brink as VP of Sales! With 20+ years in medical device sales leadership, Mac will drive our growth and help expand access to innovative cardiac care solutions nationwide. Exciting times ahead🚀! #RhythmScience #CardiacCare #Leadership #EPeeps

🎉 6 years ago, we began working to transform cardiac monitoring data into life-saving insights. Now, we're leading the way in smarter decision tools for cardiology teams. Grateful for our healthcare partners' trust as we continue innovating for heart health! #cardiology

🇺🇸 This Independence Day, we celebrate the freedom to innovate, to heal, and to protect what matters most—the heart of every patient❤️ Happy 4th of July from all of us at RhythmScience!

Today, we honor the fathers, father figures, and caregivers who give their hearts every day to the people they love. 💙Happy Father's Day!💙

Behind many data points are fathers, brothers & sons. Heart disease is the top cause of death for US men, but early detection saves lives. We're proud our data management technology provides insights that help cardiologists identify risks and intervene early. ❤️ #MensHealthWeek

Remembering and honoring the brave men and women who made the ultimate sacrifice. #MemorialDay

#WorldHypertensionDay facts: Hypertension affects 1.28 billion adults globally, yet 46% don't know they have it. It's a major cause of premature death. Your involvement + your doctor's cardiac monitoring software = better management! Knowledge is power when fighting hypertension.

🌺Happy Mother’s Day!🌺 To the mothers, stepmothers, grandmothers, mother figures, and those navigating this day with mixed emotions - we see you, we honor you, and we thank you.